U.S. Markets close in 44 mins

Quotient Limited (QTNT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.24+0.03 (+0.42%)
As of 3:15PM EST. Market open.
Sign in to post a message.
  • S
    Shawn
    JERSEY, Channel Islands, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported preliminary EU field trial performance data for its MosaiQ Expanded Immunohematology (IH) Microarray. The data suggest that tests performed with Quotient's Microarray are highly accurate.
    Bullish
  • S
    Shawn
    Quotient Limited to Participate in Two Upcoming Conferences

    Stifel Virtual Healthcare Conference
    The Company will be presenting on Tuesday, November 17, 2020 at 8:00am ET.
    Jefferies Virtual London Healthcare Conference
    The Company will be presenting on Wednesday, November 18, 2020 at 9:40am ET (2:40pm GMT).
    Bullish
  • S
    Shawn
    Blue skies and heading back to $8+
    Bullish
  • S
    Shawn
    QTNT just instituted a change of control agreement with Franz Walt. 2-3 billion market cap works for this shareholder!
    Bullish
  • S
    Shawn
    Very cheap down here after the offering. Institutions are in big and this can and will move quickly to $8+ imo. Long $QTNT
    Bullish
  • S
    Shawn
    Just had the chance to listen to the Jeffries presentation... partnering with a large US lab chain could lead to massive stock price gains
    Bullish
  • G
    Glenn
    A lot of testing is going to be taking place. Is this company going to share in this services?
  • f
    francisco
    Good report, good company
    Bullish
  • f
    francisco
    now is the best time to buy, if you see the call option over $10 and the last 3 ER are beat, balance sheet is hight, everything in this company is good, FDA gave permission too. will go to $10 easy
    Bullish
  • D
    Dieter
    As previously announced, Quotient has entered into contracts to supply its COVID-19 antibody tests to customers in the U.S. One of those customers, Bloodworks Northwest, is seeking to source convalescent blood plasma taken from donors whose blood con
    As previously announced, Quotient has entered into contracts to supply its COVID-19 antibody tests to customers in the U.S. One of those customers, Bloodworks Northwest, is seeking to source convalescent blood plasma taken from donors whose blood con
    www.quotientbd.com
  • D
    Denis
    if you have QTNT shares place a sale order with a high sale price so nobody can borrow it to short sell it
  • Y
    Yahoo Finance Insights
    Quotient is up 9.43% to 6.73
  • Y
    Yahoo Finance Insights
    Quotient is up 9.24% to 5.91
  • S
    Shawn
    Bought some yesterday and again this morning now that the offering $@*& show is behind us.
    Bullish
  • G
    Glenn
    It is a great feeling to know that real pros are also investing in this company.
    Bullish
  • J
    Jay
    Just bought a huge position at 8.37 .......I like this company !
  • P
    Peter
    Great news today.... Big move coming tomorrow
  • Y
    Yahoo Finance Insights
    Quotient is up 9.06% to 6.14
  • L
    Larry
    This is AI talking anyone out there to comment on this 20 stock in 9 months and 30 in 1 year
  • P
    Pikachu
    They keep executing. Senior notes postponed, $64m raised - demand was huge ( stock is 4% up from the offering price upon 17% dilution), SDS panel V&V data is generated, Mosaiq device CE Marked, Manufacturing facility ISO certified. 2019 / 2020 is full of development and regulatory milestones. Walt is a beat. Turned this company around completely 180%. Definitely undervalued here considering recent developments and resolved cash overhang